1-2 of 2
Authors: Lisa Kerr
Journal Article
P261 Continuing versus withdrawing ixekizumab in patients with PsA who achieved sustained minimal disease activity: results from the SPIRIT-P3 study Free
Rheumatology, Volume 59, Issue Supplement_2, April 2020, keaa111.254, https://doi.org/10.1093/rheumatology/keaa111.254
Published: 20 April 2020
Journal Article
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2 Open Access
Rheumatology, Volume 57, Issue 11, November 2018, Pages 2001–2011, https://doi.org/10.1093/rheumatology/key182
Published: 24 July 2018
